Mark Massaro
Stock Analyst at BTIG
(4.35)
# 261
Out of 4,792 analysts
137
Total ratings
49.15%
Success rate
16.77%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $7.41 | +21.46% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $44.28 | +69.38% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.36 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $5.70 | +22.81% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $3.30 | +112.12% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $159.61 | +40.97% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $138.71 | -2.67% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.22 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $80.11 | -43.83% | 4 | Jul 31, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $50 | $42.02 | +18.99% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $410.76 | +41.20% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $8.72 | +140.83% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.60 | +207.69% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.87 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.50 | +433.33% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.00 | +166.67% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $19.19 | +56.33% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.27 | +17.10% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $17.37 | +43.93% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.29 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.50 | +133.33% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.92 | +3,324.66% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.70 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $76.42 | +292.57% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $61.69 | -18.95% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $170.63 | -34.36% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $233.46 | -29.32% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $32.49 | +146.23% | 9 | Sep 10, 2018 |
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $7.41
Upside: +21.46%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $44.28
Upside: +69.38%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.36
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $5.70
Upside: +22.81%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $3.30
Upside: +112.12%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $159.61
Upside: +40.97%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $138.71
Upside: -2.67%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.22
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $80.11
Upside: -43.83%
Guardant Health
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $42.02
Upside: +18.99%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $410.76
Upside: +41.20%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $8.72
Upside: +140.83%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.60
Upside: +207.69%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.87
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $1.50
Upside: +433.33%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.00
Upside: +166.67%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $19.19
Upside: +56.33%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.27
Upside: +17.10%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $17.37
Upside: +43.93%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.50
Upside: +133.33%
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.92
Upside: +3,324.66%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $0.70
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $76.42
Upside: +292.57%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $61.69
Upside: -18.95%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $170.63
Upside: -34.36%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $233.46
Upside: -29.32%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $32.49
Upside: +146.23%